4 Minute Read
Regulatory and legal updates on four significant regulatory topics, including the Inflation Reduction Act and FSS Public Law updates.
4 Minute Read
Explore some of the key provisions and timelines of the Inflation Reduction Act for their impact on pharmaceutical manufacturers government pricing and GTN strategies.
4 Minute Read
August's market update is a legislative review of the NDC formal proposal, FTC investigation of PBMs, and the False Claims Act.
6 Minute Read
July's market update is a legislative review of 340B contract pharmacy restrictions, new Medicare bills, and SPTR updates.
4 Minute Read
This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.
6 Minute Read
Using exclusive ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.
4 Minute Read
And other industry updates including the Medi-Cal older adult expansion and profiles of new pharmacy models and 3PLs entering the market.
3 Minute Read
We recap pressing issues from the past month, including the DUNS number transition, the latest in the Eli Lilly/Streck case, and rising healthcare spending for U.S. payers.
11 Minute Read
Common manufacturer concerns on best price calculations, copay accumulators and maximizers, and 340B management as the effective date for the CMS Final Rule approaches.